HealthEquity, Inc. - Common Stock (HQY)
111.26
-0.29 (-0.26%)
NASDAQ · Last Trade: Jun 9th, 11:29 AM EDT
Detailed Quote
Previous Close | 111.55 |
---|---|
Open | 111.55 |
Bid | 111.22 |
Ask | 111.30 |
Day's Range | 109.72 - 112.72 |
52 Week Range | 65.01 - 116.65 |
Volume | 158,665 |
Market Cap | 9.28B |
PE Ratio (TTM) | 81.21 |
EPS (TTM) | 1.4 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,201,907 |
Chart
About HealthEquity, Inc. - Common Stock (HQY)
Healthequity is a leading provider of health savings accounts and other consumer-directed benefits, facilitating individuals and employers in managing healthcare expenses. The company offers a robust platform that integrates various services, including healthcare spending accounts, wellness services, and insurance products, aimed at empowering consumers to make informed healthcare decisions. By promoting cost-saving strategies and enhancing access to critical healthcare resources, Healthequity plays a vital role in the healthcare ecosystem, making it easier for users to navigate their financial responsibilities associated with medical care. Read More
News & Press Releases
Via Benzinga · June 9, 2025

Via Benzinga · June 5, 2025

Via Benzinga · June 4, 2025

Via Benzinga · June 4, 2025

Via Benzinga · June 4, 2025

Via Benzinga · June 4, 2025

Here's a look at HealthEquity's first-quarter earnings report.
Via Benzinga · June 3, 2025

HEALTHEQUITY INC (NASDAQ:HQY) shows strong growth fundamentals and a bullish technical setup, making it a stock to watch for investors seeking growth opportunities.
Via Chartmill · May 28, 2025
Via Benzinga · May 23, 2025
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · May 19, 2025
Via Benzinga · May 13, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 9, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 5, 2025
Via Benzinga · May 1, 2025
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · April 29, 2025
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 27, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · April 25, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · April 21, 2025